Calquence (Acalabrutinib) is a targeted therapy for adult patients with certain ...
per page
This website uses cookies to improve your experience. By clicking “Accept”, you consent to the use of ALL the cookies. However you may visit Cookie Settings to provide a controlled consent.
Calquence (Acalabrutinib)As low as USD $2,795.00